N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM)

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2022 Jul 11

PMID 35813230

Authors

Xufan Zhang

Qian Chen

Yuchen Li

Hongqing Chen

Qin Jiang

Qiongying Hu

Affiliations

Soon will be listed here.

Abstract

Background: NDRG1 has been reported to exhibit relatively low expression levels in glioma tissues compared with adjacent brain tissues. Additionally, NDRG1 is reported to be a tumor suppressor with the potential to suppress the proliferation, invasion, and migration of cancer cells. However, its exact roles in GBM are still unknown.

Methods: Gene Expression Profiling Interactive Analysis (GEPIA) was employed to evaluate the expression level of NDRG1 in GBM. After the introduction of NDRG1, proliferation, analyses of colony formation, migration, and invasion capacities were performed. A luciferase reporter assay was performed to detect the effect of NDRG1 on the vascular endothelial growth factor A (VEGFA) promoter.

Results: In this study, data from GBM and healthy individuals were retrospectively collected by employing GBM, and VEGFA was found to be differentially expressed in GBM tissues compared with adjacent brain tissues. Furthermore, NDRG1 expression is positively correlated with VEGFA expression, but not expression of the other two VEGF isoforms, VEGFB and VEGFC. In the glioma cell lines U87MG and U118, overexpression of NDRG1 significantly upregulated VEGFA. By performing a dual-luciferase reporter assay, it was observed that overexpressed NDRG1 transcriptionally activated VEGFA. Expectedly, overexpression of NDRG1 decreased cell viability by blocking cell cycle phases at G1 phase. Additionally, overexpression of NDRG1 inhibited invasion, colony formation, and tumor formation in soft agar. Remarkably, VEGFA silencing or blockade of VEGF receptor 2 (VEGFR2) further inhibited malignant behaviors in soft agar, including proliferation, invasion, colony formation, and tumor formation.

Conclusions: NDRG1-induced VEGFA exerts protective effects in GBM via the VEGFA/VEGFR2 pathway. Therefore, targeting both NDRG1 and VEGFA may represent a novel therapy for the treatment of GBM.

Citing Articles

Retraction: Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2.

PLoS One. 2024; 19(3):e0300802.

PMID: 38530792 PMC: 10965087. DOI: 10.1371/journal.pone.0300802.

Retracted: N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).

International B Biomed Res Int. 2023; 2023:9794063.

PMID: 37829051 PMC: 10567427. DOI: 10.1155/2023/9794063.

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration.

Li T, Wang L, Yu N, Zeng A, Huang J, Long X Front Oncol. 2023; 12:1055308.

PMID: 36713580 PMC: 9876620. DOI: 10.3389/fonc.2022.1055308.

References

Vredenburgh J, Desjardins A, Herndon 2nd J, Dowell J, Reardon D, Quinn J . Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007; 13(4):1253-9. DOI: 10.1158/1078-0432.CCR-06-2309. View

Vredenburgh J, Desjardins A, Herndon 2nd J, Marcello J, Reardon D, Quinn J . Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol. 2007; 25(30):4722-9. DOI: 10.1200/JCO.2007.12.2440. View

Strzelczyk B, Szulc A, Rzepko R, Kitowska A, Skokowski J, Szutowicz A . Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol. 2009; 16(5):1287-94. DOI: 10.1245/s10434-009-0381-0. View

Yang Y, Cheng Y, Yang L, Shi G, Chen P, Li L . The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population. Cell Mol Neurobiol. 2021; 42(6):1949-1964. PMC: 11421688. DOI: 10.1007/s10571-021-01075-6. View

Watari K, Shibata T, Nabeshima H, Shinoda A, Fukunaga Y, Kawahara A . Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice. Sci Rep. 2016; 6:19470. PMC: 4726041. DOI: 10.1038/srep19470. View

Mitre A, Florian A, Buruiana A, Boer A, Moldovan I, Soritau O . Ferroptosis Involvement in Glioblastoma Treatment. Medicina (Kaunas). 2022; 58(2). PMC: 8876121. DOI: 10.3390/medicina58020319. View

Cai C, Wang X, Fu Q, Chen A . The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. World J Surg Oncol. 2022; 20(1):40. PMC: 8859901. DOI: 10.1186/s12957-022-02511-7. View

Liu W, Iiizumi-Gairani M, Okuda H, Kobayashi A, Watabe M, Pai S . KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer. J Biol Chem. 2011; 286(21):18949-59. PMC: 3099710. DOI: 10.1074/jbc.M111.232637. View

Narayanan A, Gagliardi F, Gallotti A, Mazzoleni S, Cominelli M, Fagnocchi L . The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1. Cell Death Differ. 2018; 26(9):1813-1831. PMC: 6748080. DOI: 10.1038/s41418-018-0248-7. View

10.

Bolteus A, Berens M, Pilkington G . Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep. 2002; 1(3):225-32. DOI: 10.1007/s11910-001-0022-x. View

11.

Grossman R, Heath A, Ferretti V, Varmus H, Lowy D, Kibbe W . Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016; 375(12):1109-12. PMC: 6309165. DOI: 10.1056/NEJMp1607591. View

12.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

13.

Shu H, Peng Y, Hang W, Zhang M, Shen L, Wang D . Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter. Acta Pharmacol Sin. 2022; 43(10):2550-2561. PMC: 9525722. DOI: 10.1038/s41401-022-00877-8. View

14.

Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman F . Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol. 2002; 118(5):399-408. DOI: 10.1007/s00418-002-0460-9. View

15.

Nakahara Y, Ito H, Namikawa H, Furukawa T, Yoshioka F, Ogata A . A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas. Brain Sci. 2022; 12(4). PMC: 9029626. DOI: 10.3390/brainsci12040473. View

16.

Lai L, Su Y, Chen K, Tsai M, Sher Y, Lu T . Down-regulation of NDRG1 promotes migration of cancer cells during reoxygenation. PLoS One. 2011; 6(8):e24375. PMC: 3166165. DOI: 10.1371/journal.pone.0024375. View

17.

Wang Y, Jiang T . Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett. 2013; 331(2):139-46. DOI: 10.1016/j.canlet.2012.12.024. View

18.

Ito H, Watari K, Shibata T, Miyamoto T, Murakami Y, Nakahara Y . Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma. Cancer Res. 2019; 80(2):234-248. DOI: 10.1158/0008-5472.CAN-19-0438. View

19.

Ma W, Na M, Tang C, Wang H, Lin Z . Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep. 2015; 12(1):1050-8. PMC: 4438970. DOI: 10.3892/mmr.2015.3492. View